173 related articles for article (PubMed ID: 36866739)
1. Transfer of exosomal microRNAs confers doxorubicin resistance in osteosarcoma cells.
Cai T; Zhang C; Zhan T
Mol Med Rep; 2023 Apr; 27(4):. PubMed ID: 36866739
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA expression profiles of the doxorubicin-resistant human osteosarcoma cell line MG63/DXR and its parental cell line MG63 as ascertained by microarray analysis.
Zhu KP; Zhang CL; Shen GQ; Zhu ZS
Int J Clin Exp Pathol; 2015; 8(8):8754-73. PubMed ID: 26464619
[TBL] [Abstract][Full Text] [Related]
3. Exosomal miR-331-3p derived from chemoresistant osteosarcoma cells induces chemoresistance through autophagy.
Meng C; Yang Y; Feng W; Ma P; Bai R
J Orthop Surg Res; 2023 Nov; 18(1):892. PubMed ID: 37993925
[TBL] [Abstract][Full Text] [Related]
4. Multimodal transfer of MDR by exosomes in human osteosarcoma.
Torreggiani E; Roncuzzi L; Perut F; Zini N; Baldini N
Int J Oncol; 2016 Jul; 49(1):189-96. PubMed ID: 27176642
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin-resistant osteosarcoma cell-derived exosomes confer cisplatin resistance to recipient cells in an exosomal circ_103801-dependent manner.
Pan Y; Lin Y; Mi C
Cell Biol Int; 2021 Apr; 45(4):858-868. PubMed ID: 33325136
[TBL] [Abstract][Full Text] [Related]
6. TFAP2C-mediated LINC00922 signaling underpins doxorubicin-resistant osteosarcoma.
Gu Z; Zhou Y; Cao C; Wang X; Wu L; Ye Z
Biomed Pharmacother; 2020 Sep; 129():110363. PubMed ID: 32563982
[TBL] [Abstract][Full Text] [Related]
7. The promising roles of exosomal microRNAs in osteosarcoma: A new insight into the clinical therapy.
Tian W; Niu X; Feng F; Wang X; Wang J; Yao W; Zhang P
Biomed Pharmacother; 2023 Jul; 163():114771. PubMed ID: 37119740
[TBL] [Abstract][Full Text] [Related]
8. [Sensitivity of doxorubicin-resistant osteosarcoma cells to doxorubicin regulated by long non-coding RNA NR_036444].
Zhu KP; Zhang CL
Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):250-255. PubMed ID: 28550663
[No Abstract] [Full Text] [Related]
9. MicroRNA‑22 inhibits the proliferation and migration, and increases the cisplatin sensitivity, of osteosarcoma cells.
Zhou X; Natino D; Zhai X; Gao Z; He X
Mol Med Rep; 2018 May; 17(5):7209-7217. PubMed ID: 29568877
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA‑22 mediates the cisplatin resistance of osteosarcoma cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Xue HQ; Sun L; Sun C; Feng W; Guo SB
Oncol Rep; 2020 Apr; 43(4):1169-1186. PubMed ID: 32323781
[TBL] [Abstract][Full Text] [Related]
11. Sphingosine kinase 1 contributes to doxorubicin resistance and glycolysis in osteosarcoma.
Ren X; Su C
Mol Med Rep; 2020 Sep; 22(3):2183-2190. PubMed ID: 32705189
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-184 Modulates Doxorubicin Resistance in Osteosarcoma Cells by Targeting BCL2L1.
Lin BC; Huang D; Yu CQ; Mou Y; Liu YH; Zhang DW; Shi FJ
Med Sci Monit; 2016 May; 22():1761-5. PubMed ID: 27222034
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-301a modulates doxorubicin resistance in osteosarcoma cells by targeting AMP-activated protein kinase alpha 1.
Zhang Y; Duan G; Feng S
Biochem Biophys Res Commun; 2015 Apr; 459(3):367-73. PubMed ID: 25727016
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA‑22 regulates autophagy and apoptosis in cisplatin resistance of osteosarcoma.
Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Sun L; Sun C; Feng W; Guo SB
Mol Med Rep; 2020 Nov; 22(5):3911-3921. PubMed ID: 33000186
[TBL] [Abstract][Full Text] [Related]
15. Stathmin is key in reversion of doxorubicin resistance by arsenic trioxide in osteosarcoma cells.
Feng T; Qiao G; Feng L; Qi W; Huang Y; Yao Y; Shen Z
Mol Med Rep; 2014 Dec; 10(6):2985-92. PubMed ID: 25310700
[TBL] [Abstract][Full Text] [Related]
16. Hsa_circ_0004674 promotes osteosarcoma doxorubicin resistance by regulating the miR-342-3p/FBN1 axis.
Bai Y; Li Y; Bai J; Zhang Y
J Orthop Surg Res; 2021 Aug; 16(1):510. PubMed ID: 34407841
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of circITCH promotes osteosarcoma development and resistance to doxorubicin via the miR-524/RASSF6 axis.
Zhou W; Liu Y; Wu X
J Gene Med; 2021 Oct; 23(10):e3373. PubMed ID: 34151476
[TBL] [Abstract][Full Text] [Related]
18. Tumor suppressing role of serum-derived exosomal microRNA-15a in osteosarcoma cells through the GATA binding protein 2/murine double minute 2 axis and the p53 signaling pathway.
Wu C; Li Z; Feng G; Wang L; Xie J; Jin Y; Wang L; Liu S
Bioengineered; 2021 Dec; 12(1):8378-8395. PubMed ID: 34592889
[TBL] [Abstract][Full Text] [Related]
19. Circular RNA LARP4 correlates with decreased Enneking stage, better histological response, and prolonged survival profiles, and it elevates chemosensitivity to cisplatin and doxorubicin via sponging microRNA-424 in osteosarcoma.
Hu Y; Gu J; Shen H; Shao T; Li S; Wang W; Yu Z
J Clin Lab Anal; 2020 Feb; 34(2):e23045. PubMed ID: 31642110
[TBL] [Abstract][Full Text] [Related]
20. Characterization of multidrug‑resistant osteosarcoma sublines and the molecular mechanisms of resistance.
Yang JZ; Ma SR; Rong XL; Zhu MJ; Ji QY; Meng LJ; Gao YY; Yang YD; Wang Y
Mol Med Rep; 2016 Oct; 14(4):3269-76. PubMed ID: 27498972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
